secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orchestra BioMed Holdings, Inc. (OBIO)
CIK:        0001814114
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001104659-25-062105
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Orchestra BioMed stockholders elect directors, ratify auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- Class II directors Chris Cleary, Pamela Connealy, David Pacitti elected to serve until 2028.
- Ernst & Young LLP ratified as independent auditor for fiscal year ending Dec. 31, 2025.
- 28,177,159 of 38,312,512 eligible shares represented at the June 24, 2025 annual meeting.
- Each director received over 24.5 million votes for and ~3.6 million broker non-votes.
- Auditor ratification passed with 28,140,709 votes for, 34,087 against, 2,363 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1814114/000110465925062105/0001104659-25-062105-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1814114/000110465925062105/tm2518830d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-062105

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer